When Rajiv Bhushans father complained of blurry, browned vision and pain from bright lights, doctors told him that surgically replacing his eyes lenses was the only way to correct the cataracts that had left him legally blind. Instead, after learning that cataracts result from an age-related accumulation of proteins and lipids in a persons lens, Bhushan, an electrical engineer, set to work concocting a chemical solution to break up the molecules clouding his fathers eyes. Six years later, the eyedrops, called C-KAD, are entering the final stages of clinical testing. If all goes well, they will hit pharmacy shelves in two years, becoming the first non-surgical treatment.
Arrow This is a very interesting article which shows promise for individuals with severe eye problems, and there are millions of us. I would like to be involved in this study as my Doctor, that happens to be a leader in national eye care is not able to improve my sight. A previous comment was a valid indication of some Ophthalmologists not wanting to impair their lucrative cataract replacement business. This of course could hurt widespread distribution of the C-KAD product throughout the United States and other countries. I look forward to seeing articles of this nature in your extremely fine magazine.
Stay up to date on the latest news of the future of science and technology from your iPhone with full articles, images and offline viewing
Featuring every article from the magazine and website, plus links from around the Web. Also see our PopSci DIY feed
Share links with friends, comment on stories and more
In our December issue, Popular Science names the 100 best innovations of the year: bombproof wallpaper, self-parking cars, the fastest helicopter, and 97 more. Plus inventor profiles and videos.
Check out the best of what's new here.